This ‘overlooked’ Trump beneficiary can soar nearly 80%, according to Bank of AmericaFebruary 25, 2025
Forexlive European FX news wrap: Cautious mood as we await the US consumer confidence dataFebruary 25, 2025
Market Trends Amgen targets $34.3B-$35.7B in 2025 revenues with strong growth in key therapeutic areas (NASDAQ:AMGN)By admin8996erT0allFebruary 5, 2025 Seeking Alpha’s Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking…
Market Trends Amgen Lumakras cleared for colorectal cancer (AMGN:NASDAQ)By admin8996erT0allJanuary 17, 2025 Mario Tama/Getty Images NewsThe U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) KRASG12C inhibitor Lumakras as part of…
